Check out our review with @idomyownexpts.bsky.social ! ARF GTPases
Check out our review with @idomyownexpts.bsky.social ! ARF GTPases
International collaboration with the amazing team of Fabien Le Grand @cnrs.fr (including Ph.D. student Julie Sitolle) and Wojciech Krezel @igbmc.bsky.social (and Ph.D. student Yash Parekh).
Collaboration with @ircm.bsky.social colleagues: Cayouette lab (Awais Javed and @michelcayouette.bsky.social), Malleshaiah lab (Loïck Joumier and Mohan Malleshaiah), Yacine Kherdjimil, leader of the "Disease modelling and Gene Editing" platform, and Konstantin Ketchoumian. @umontreal-en.bsky.social
Proud to share our new collaborative work in @dev-journal.bsky.social led by talented Ph.D. student Sarah Nahlé!
We reveal that vertebrate myogenesis involves two transcriptionally distinct myocyte states:
Mc1 (Mymk+Mymx+)
Mc2 (Mymk+)
journals.biologists.com/dev/article-...
#myogenesis
Thanks Matt!
Congrats to #JF_CoteLab and colleagues for their new #DevelopmentJ paper: Differentially expressed fusogens specify myocyte states to drive myogenesis. #Myoblue tinyurl.com/ykbbex8t
Dock8 and Mst1 identified as necessary components of this mechanosensitive pathway, which is revealing for patients with immunodeficiencies caused by loss-of-function mutations in Dock8 where immune cells are entangled in dense environments but migrate well on 2D surfaces
Vous devez lire cet article! www.journaldemontreal.com/2025/07/28/l...
Un espoir pour stopper la propagation du cancer : un étude des Drs Côté et Elkholi parue dans «Cancer Research» Il s’agit d’un nouvel espoir de comprendre et de limiter la récurrence métastatique du cancer du sein. Les récidives qui surviennent dans d’autres organes ou qui se réveillent après une période de dormance ne sont pas bienvenues. On découvre que la protéine PIK3C3 est essentielle à la survie des cellules cancéreuses dormantes. En ciblant cette protéine, les chercheurs ont pu éliminer ces cellules dormantes avant qu'elles ne déclenchent une récidive. Bravo à la recherche!
Une avancée prometteuse contre la propagation du cancer du sein: une étude des Drs Côté et Elkholi parue dans «Cancer Research»
Il s’agit d’un nouvel espoir de comprendre et de limiter la récurrence métastatique du cancer du sein.
Bravo à la recherche!
bit.ly/4murFYh
Laura Quirion and myself will be discussing RAS signalling at this cool meeting. Looking forward to see old friends and make new colleagues #BiochemEvent
@biochemsoc.bsky.social
Amazing Basic to Clinical Oncology meeting at the @ircm.bsky.social today. What a pleasure to hear and meet @sohailtavazoie.bsky.social Beautiful #metastasis work!
Quel honneur pour Dre Rebecca Cusseddu et moi de venir vulgariser nos travaux sur les métastases du cancer du sein devant une salle comble. @ircm.bsky.social @umontreal-en.bsky.social #Fondation Québécoise du Cancer du Sein
Félicitations à Anna Maria Lazaratos de notre équipe pour son prix d’excellence- présentation orale à la journée du département de médecine de @umontreal-en.bsky.social
Congrats Ryan and Kelly!
Congrats to Ryan and Kelly for this excellent publication. I am so glad they could use our original Dock cKO mouse.
What do I do at YYZ airport? Of course … listen to Rush classic song YYZ!
Congrats Laura!
Can't wait for the end of this day! Dad/son evening. My son will finally see @mikeportnoy.bsky.social on the drum kit!
www.placedesarts.com/en/event/dre...
#proud-mentor!
Congrats to Laura Quirion, a Ph.D. student in my lab @ircm.bsky.social , who was awarded a prize from the @fondsrechercheqc.bsky.social recogninzing the quality of her publication:
frq.gouv.qc.ca/histoire-et-...
theahl.com/news/picard-...
Congrats to my cousin's husband and my friend Michel Picard for being elected into the AHL Hall of Fame. What an amazing career. Still active, now with the St-Louis Blues scouting team.
www.linkedin.com/feed/update/...
Don't miss the SNCC meeting in Banff, taking place in the breathtaking surroundings of Banff, Canada!
We will select the short talks soon, so make sure to register and submit an abstract. If you are a early-mid carrer investigators, this is a great opportunity